ECCO2R
Sponsors
Guy's and St Thomas' NHS Foundation Trust, Rexecor, University of Giessen, University of Bologna, Li Xuyan
Conditions
AKIARDSCOPD Acute ExacerbationChronic Obstructive Pulmonary DiseaseHypercapnic Respiratory FailureLung Diseases, ObstructivePatients With Acute Exacerbation of Chronic Obstructive Pulmonary DiseasePatients With Acute Respiratory Distress Syndrome
Unknown Phase
ECCO2R as an Adjunct to NIV in AECOPD
CompletedNCT02086084
Start: 2015-12-01End: 2020-12-31Updated: 2021-08-11
Registry on the EXperience of Extracorporeal CO2 Removal in Intensive Care Units
NCT02965079
Start: 2016-01-31End: 2022-06-30Target: 200Updated: 2020-10-14
Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome
CompletedNCT04351906
Start: 2020-05-03End: 2024-12-31Updated: 2025-03-04
Extracorporeal CO2 Removal for Acute Decompensation of COPD
WithdrawnNCT04582799
Start: 2024-08-01End: 2024-08-01Updated: 2025-04-01
ECCO2R in the Treatment of Acute Exacerbation of COPD With Severe Hypercapnia
NCT04842344
Start: 2021-05-01End: 2024-03-31Target: 176Updated: 2021-04-13
CO2 Removal in Severe Acute exacerbatIons of Chronic Obstructive Lung Diseases
Active, not recruitingNCT05546606
Start: 2023-04-18End: 2025-03-11Updated: 2024-08-05